Microfluidic tissue model

US10018620B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10018620-B2
Application numberUS-201514688678-A
CountryUS
Kind codeB2
Filing dateApr 16, 2015
Priority dateApr 16, 2014
Publication dateJul 10, 2018
Grant dateJul 10, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure describes systems and methods for mimicking body tissue and the function thereof. The mimicked body tissue can include kidney tissue, the blood brain barrier, and other tissues. In some implementations, the systems described herein are used to test the impact of controlled factors on the tissue. The controlled factors can include flow rates, shear rates, and test chemicals (e.g., therapeutics and toxins). In some implementations, the system and methods are used to test pharmaceutical and biological therapies, characterize healthy or diseased tissue, and observe phenomena of the tissue in vitro.

First claim

Opening claim text (preview).

The invention claimed is: 1. A culture device comprising: a first layer having a membrane-adjacent surface and a first microfluidic channel having a recessed surface and two sidewalls defined into the first layer, wherein the two sidewalls connect the recessed surface to the membrane adjacent surface; a first graduated microfluidic channel defined into the first layer such that a height of the first graduated microfluidic channel is between about ⅛ and about ⅔ of a height of the first microfluidic channel and the first graduated microfluidic channel is in fluid communication with the first microfluidic channel; a second layer having a membrane-adjacent surface and a second microfluidic channel having a recessed surface and two sidewalls defined into the second layer, wherein the two sidewalls connect the recessed surface to the membrane adjacent surface; a membrane separating the first microfluidic channel of the first layer from the second microfluidic channel of the second layer and in contact with the membrane-adjacent surfaces of the first and second layers; a plurality of first electrodes disposed in the first microfluidic channel, wherein the first electrodes cover at least a portion of the recessed surface of the first microfluidic channel; and a plurality of second electrodes disposed in the second microfluidic channel, wherein the second electrodes cover at least a portion of the recessed surface of the second microfluidic channel. 2. The device of claim 1 , further comprising a second graduated microfluidic channel in fluidic communication with the second microfluidic channel. 3. The device of claim 1 , wherein the first and second electrodes are between about 0.5 μm and about 15 μm thick. 4. The device of claim 2 , wherein a height of the second graduated microfluidic channel is between about ⅛ and about ⅔ of a height of the second microfluidic channel. 5. The device of claim 1 , further comprising a transition channel between an inlet of the first microfluidic channel and the first microfluidic channel, wherein an angle between a wall of the transition channel and the membrane is between about 10 degrees and about 30 degrees. 6. The device of claim 1 , further comprising an imager. 7. The device of claim 1 , further comprising at least one valve to control a fluid flow into the first microfluidic channel and the second microfluidic channel. 8. The device of claim 1 , wherein the first and second electrodes are configured to measure a trans-epithelial electrical resistance across the membrane. 9. The device of claim 1 , wherein the first layer and the second layer comprise a cyclic olefin copolymer. 10. The device of claim 1 , wherein the first electrodes run up one of the sidewalls of the first microfluidic channel and extend across a portion of the membrane-adjacent surface of the first layer, and the second electrodes run up one of the sidewalls of the second microfluidic channel and extend across a portion of the membrane-adjacent surface of the second layer. 11. The device of claim 1 , wherein the first and second electrodes are less than 15 μm thick.

Assignees

Inventors

Classifications

  • C12M23/16Primary

    Microfluidic devices; Capillary tubes (integrated microfluidic structures B01L3/5027; microreactors B01J19/0093) · CPC title

  • on expression patterns · CPC title

  • of biomass, e.g. colony counters or by turbidity measurements (electrooptical investigation of individual particles G01N15/14, flow cytometers G01N15/1404) · CPC title

  • Means for regulation, monitoring, measurement or control, e.g. flow regulation (controlling or regulating chemical, physical or physicochemical processes B01J19/0006; heating or cooling apparatus for laboratory use B01L7/00; electro optical investigation of individual particles, flow cytometers G01N15/14; automatic analysis G01N35/00; controlling or regulating in general G06N) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10018620B2 cover?
The present disclosure describes systems and methods for mimicking body tissue and the function thereof. The mimicked body tissue can include kidney tissue, the blood brain barrier, and other tissues. In some implementations, the systems described herein are used to test the impact of controlled factors on the tissue. The controlled factors can include flow rates, shear rates, and test chemical…
Who is the assignee on this patent?
Charles Stark Draper Laboratory Inc
What technology area does this patent fall under?
Primary CPC classification C12M23/16. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).